These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89. Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program. Greenblatt DJ; Koch-Weser J Drugs; 1974; 7(1):118-29. PubMed ID: 4151696 [No Abstract] [Full Text] [Related]
90. Use of anticholinergics to treat bradycardia caused by alpha1-adrenergic agonist overdose is not safe. Sprung J; Alhaddad ST J Clin Anesth; 1996 Aug; 8(5):426-7. PubMed ID: 8832455 [No Abstract] [Full Text] [Related]
91. Symptomatic bradycardia associated with topical brimonidine gel (Mirvaso) administration: a case report. Jesudason DI; Appalanaidu N; Khan A Eur Heart J Case Rep; 2024 Jul; 8(7):ytae329. PubMed ID: 39045525 [TBL] [Abstract][Full Text] [Related]
92. The benefit of scratch patch testing to demonstrate ocular contact allergy to brimonidine tartrate. Ringuet J; Lajoie C; Bourgault S; Simonyan D; Houle MC Contact Dermatitis; 2022 Oct; 87(4):336-342. PubMed ID: 35642327 [TBL] [Abstract][Full Text] [Related]
93. Safety concerns regarding use of topical brimonidine for hemostasis. Weiss J; Rosen A; Shagalov DR; Weiss E J Am Acad Dermatol; 2018 Jun; 78(6):e155. PubMed ID: 29754892 [No Abstract] [Full Text] [Related]